FDA issued an EUA for certain products from the neuraminidase class of antivirals - Zanamivir and oseltamivir Phosephase.  These authorizations follow the determination by Acting HHS Secretary Charles Johnson that a public health emergency exists involving 2009 H1N1.

FDA issued an EUA for certain personal respiratory protection devices.  The authorization follows the determination by Acting HHS Secretary Charles E. Johnson that a public health emergency exists involving 2009 H1N1

On September 23, 2008, the Secretary of the Department of Homeland Security determined that there is a significant potential for a domestic emergency, involving a heightened risk of attack with a specified biological, chemical, radiological, or nuclear agent or agents--in this case, Bacillus anthracis.   Pursuant to section 564(b)(2)(B) of the Federal Food, Drug and Cosmetic Act, 21 U.S.C. §360bbb-3(b)(b)(B), and on the basis of such determination, Secretary Sebelius renewed the October 1, 2008 declaration by former Secretary Michael O. Leavitt, which was previously renewed on October 1, 2009, of an emergency justifying the authorization of the emergency use of doxycycline hyclate tablets accompanied by emergency use information subject to the terms of any authorization issued under 21 U.S.C. §360bbb-3(a).